Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Renalytix plc - Sponsored ADR (RNLXY) had Return on Equity of 291.43% for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
$3.00M |
|
$-20.40M |
|
$1.80M |
|
$1.20M |
|
$20.20M |
|
$-17.20M |
|
$-4.60M |
|
$-21.80M |
|
$-21.20M |
|
$-20.40M |
|
$-20.40M |
|
$-20.40M |
|
$-19.76M |
|
$-17.20M |
|
$-17.20M |
|
5.83M |
|
5.83M |
|
$-3.50 |
|
$-3.50 |
|
| Balance Sheet Financials | |
$5.80M |
|
$0.20M |
|
$0.30M |
|
$6.10M |
|
$4.80M |
|
$8.30M |
|
$8.30M |
|
$13.10M |
|
$-7.00M |
|
$-7.00M |
|
$-7.00M |
|
6.62M |
|
| Cash Flow Statement Financials | |
$-17.90M |
|
$0.00M |
|
$16.00M |
|
$4.70M |
|
$3.60M |
|
$-1.10M |
|
$3.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.21 |
|
-- |
|
-- |
|
6.38 |
|
-1.19 |
|
40.00% |
|
-573.33% |
|
-573.33% |
|
-573.33% |
|
-726.67% |
|
-680.00% |
|
$-17.90M |
|
-- |
|
-- |
|
-- |
|
0.49 |
|
9.00 |
|
5.00 |
|
73.00 |
|
|
Return on Equity |
291.43% |
291.43% |
|
-334.43% |
|
-1569.23% |
|
$-1.06 |
|
$-3.07 |
|
$-3.07 |
|